门类型和扩张后对跨假肢梯度的影响在接受过导管大动脉门在门手术的患者中
Manuela Muratori1, Laura Fusini1,2, Gloria Tamborini1
1Perioperative Cardiology and Cardiovascular Imaging Department, Centro Cardiologico Monzino IRCCS, via Parea 4, 20138 Milan, Italy.
European heart journal. Imaging methods and practice
|May 15, 2025
概括
门内透管大动脉置换 (ViV-TAVR) 有效地治疗退化的生物假体门. 具有气球后扩张的自扩展实现了最低的跨假肢梯度,改善了血液动力学.
科学领域:
- 心脏病学 心脏病学
- 干预心脏病学 干预心脏病学
- 生物医学工程 生物医学工程
背景情况:
- 退化的生物假体大动脉往往需要重新干预.
- 门内透管大动脉置换 (ViV-TAVR) 为这些患者提供了一种不那么侵入性的选择.
- 与原生门TAVR相比,ViV-TAVR后可以发生更高的跨假肢梯度.
研究的目的:
- 评估不同类型的透气管和气球扩张后对ViV-TAVR心声图结果的影响.
- 评估这些因素对接受ViV-TAVR的患者死亡率的影响.
主要方法:
- 一项前性研究招募了111名接受ViV-TAVR的患者.
- 患者接受了气球膨胀,没有扩张后的自我膨胀或扩张后的自我膨胀.
- 在基线,出院和6-12个月的随访期间进行了跨胸腔心声扫描.
主要成果:
- 在99%的患者中,ViV-TAVR是成功的.
- 所有组都显示了手术后跨假肢梯度的显著减少.
- 在放电和随访时观察到的最低平均梯度是在气球扩张后组 (12 ± 7 mmHg) 的自扩展中观察到的.
结论:
- ViV-TAVR对未成功的外科主动脉假体有效,改善了血液动力学.
- 过导管类型和气球扩张后影响术后梯度.
- 具有气球后扩张的自扩展显示出优异的梯度减小.
相关概念视频
Mitral Valve Prolapse I: Introduction
IntroductionThe mitral valve, one of the heart's four valves, regulates blood flow. These valves have flaps that open and close to direct blood properly through the heart and body. During each heartbeat, the flaps open for blood to pass through and seal shut to prevent backflow. Specifically, the mitral valve opens to allow blood flow from the heart's upper left chamber to the lower left chamber. It then closes securely as the lower left chamber contracts to pump blood to the body, preventing...
Mitral Stenosis I: Introduction
Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Mitral Stenosis III: Medical Management
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Aortic Regurgitation I: Introduction
IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...
Aortic Regurgitation II: Clinical Features and Diagnostic Tests
Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
Aortic Regurgitation III: Medical Management
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...


